nasal continuous positive airway pressure
nasal continuous positive airway pressure is a medical device with 10 clinical trials. Historical success rate of 85.7%.
Success Metrics
Based on 6 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
0
Mid Stage
2
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
75.0%
6 of 8 finished
25.0%
2 ended early
0
trials recruiting
10
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
NIV-MISA-NRDS Trial: a Multicenter Study in China
Nasal Bubble Continuous Positive Airway Pressure in Reducing Respiratory Distress in Children With Bronchiolitis
Prophylactic nCPAP in the PACU Following Elective Laparotomy for Bowel Surgery
Does The Surfactant Administration by Aerosolization Effective?
Non-invasive Ventilation With Neurally Adjusted Ventilatory Assist Versus Nasal Continuous Airway Pressure in Premature Infants
Clinical Trials (10)
NIV-MISA-NRDS Trial: a Multicenter Study in China
Nasal Bubble Continuous Positive Airway Pressure in Reducing Respiratory Distress in Children With Bronchiolitis
Prophylactic nCPAP in the PACU Following Elective Laparotomy for Bowel Surgery
Does The Surfactant Administration by Aerosolization Effective?
Non-invasive Ventilation With Neurally Adjusted Ventilatory Assist Versus Nasal Continuous Airway Pressure in Premature Infants
Infant Pulmonary Mechanics: High Flow Nasal Cannula Versus Nasal CPAP
Obstructive Sleep Apnea and Diabetes Mellitus
Sleep Apnea-hypopnea Syndrome (SAHS) and Ventricular Arrhythmias
Influence of nCPAP on Metabolic Consequences Associated With OSAS
Randomized Trial of Nasal Continuous Positive Airway Pressure or Synchronized Nasal Ventilation in Premature Infants.
All 10 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 10